IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) was the recipient of a large decrease in short interest in April. As of April 30th, there was short interest totalling 222,900 shares, a decrease of 35.5% from the April 15th total of 345,800 shares. Based on an average daily volume of 288,900 shares, the short-interest ratio is presently 0.8 days. Currently, 0.5% of the shares of the company are short sold.
Shares of NASDAQ:IMCC opened at $1.02 on Friday. The company’s 50 day moving average price is $1.69 and its two-hundred day moving average price is $2.44. IM Cannabis has a 12-month low of $0.84 and a 12-month high of $6.35. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.04 and a current ratio of 1.65.
IM Cannabis (NASDAQ:IMCC – Get Rating) last announced its earnings results on Thursday, March 31st. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.12). The business had revenue of $15.96 million for the quarter. IM Cannabis had a negative return on equity of 10.04% and a negative net margin of 31.34%. As a group, sell-side analysts forecast that IM Cannabis will post 0.14 EPS for the current year.
Separately, Zacks Investment Research upgraded shares of IM Cannabis from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 5th.
About IM Cannabis (Get Rating)
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands.
Further Reading
- Get a free copy of the StockNews.com research report on IM Cannabis (IMCC)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.